Table 3.
Multivariate Regression of Variables Associated With Atypical Femoral Fracture
| Unadjusted OR (95% CI) | Adjusted OR (95% CI) | |
|---|---|---|
| Age (years) | 0.98 (0.96, 1.00) a | 1.00 (0.93, 1.07) |
| Female | 2.21 (1.06, 4.63) a | 1.94 (0.41, 9.16) |
| Creatinine | 0.99 (0.98, 0.99) a | 0.99 (0.98, 1.01) |
| Charlson comorbidity score | 0.79 (0.68, 0.92) a | 0.89 (0.57, 1.41) |
| Rheumatoid arthritis | 7.58 (1.98, 28.97) a | 0.29 (0.01, 6.59) |
| Type 2 diabetes mellitus | 0.24 (0.11, 0.49) a | 0.23 (0.06, 0.95) a |
| Bisphosphonate | 8.17 (4.63, 14.4) a | 6.65 (2.35, 18.9) a |
| Denosumab | 5.84 (0.81, 42.1) | 1.09 (0.05, 23.5) |
| Surgical management | 5.74 (2.04, 16.1) a | 5.91 (0.63, 55.7) |
| Glucocorticoid use | 6.06 (1.71, 21.5) a | 0.33 (0.03, 3.83) |
| T total hip | 1.53 (1.14, 2.05) a | 1.57 (1.04, 2.37) a |
OR = odds ratio; CI = confidence interval.
a
p < 0.05.